×
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis
Sandborn WJ., Colombel JF., Frankel M., Hommes D., Lowder JN., Mayer L., Plevy S., Stokkers P., Travis S., Van Assche G., Baumgart DC., Targan SR.
DOI
10.1136/gut.2009.205443
Type
Journal article
Journal
Gut
Publisher
BMJ
Publication Date
01/11/2010
Volume
59
Pages
1485 - 1492